| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
-Induced Signal Transducer and Activator of Transcription-1 Activation and Expression of the Inducible Isoform of Nitric Oxide Synthase in INS-1 Cells
Department of Internal Medicine, University of Tokyo School of Medicine, Tokyo 113-0033, Japan
Address all correspondence and requests for reprints to: Dr. Nobuo Sekine, Department of Internal Medicine, University of Tokyo School of Medicine, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. E-mail: nobuosek-tky{at}umin.ac.jp
Interferon-
and TNF
synergistically induce the inducible
isoform of nitric oxide synthase and elicit severe cytotoxicity in
pancreatic ß-cells. We demonstrate here that GH, the well known
ß-cell mitogen, inhibits nitric oxide production by reducing
inducible nitric oxide synthase gene induction by the two cytokines and
counteracts their cytotoxic effect in insulin-secreting INS-1 cells. To
elucidate the underlying mechanism, we examined activation of the
transcription factors implicated in the induction of inducible nitric
oxide synthase, signal transducer and activator of transcription-1, and
nuclear factor-
B. GH inhibited tyrosine phosphorylation and DNA
binding of signal transducer and activator of transcription-1 promoted
by interferon-
, whereas nuclear factor-
B activation by TNF
was
not affected by GH. GH was found to induce suppressor of cytokine
signaling-1 and -3, both of which are able to inhibit interferon-
activation of signal transducer and activator of transcription-1,
suggesting that they are likely to mediate the inhibitory action of GH.
Finally, exposure of INS-1 cells to interferon-
resulted in the
impairment of insulin secretion in response to glucose, which was
restored by the addition of GH. These results indicate that GH
counteracts the effect of interferon-
through the inhibition of
signal transducer and activator of transcription-1. This action of GH
may be sufficient to suppress the synergistic induction of inducible
nitric oxide synthase by interferon-
and TNF
, thereby preventing
the cytotoxicity to ß-cells.
This article has been cited by other articles:
![]() |
C. Grasemann, F. Ratjen, D. Schnabel, E. Reutershahn, U. Vester, and H. Grasemann Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients Eur. Respir. J., April 1, 2008; 31(4): 815 - 821. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jensen, E. D Galsgaard, A. E Karlsen, Y. C Lee, and J. H Nielsen STAT5 activation by human GH protects insulin-producing cells against interleukin-1{beta}, interferon-{gamma} and tumour necrosis factor-{alpha}-induced apoptosis independent of nitric oxide production J. Endocrinol., October 1, 2005; 187(1): 25 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Brelje, L. E. Stout, N. V. Bhagroo, and R. L. Sorenson Distinctive Roles for Prolactin and Growth Hormone in the Activation of Signal Transducer and Activator of Transcription 5 in Pancreatic Islets of Langerhans Endocrinology, September 1, 2004; 145(9): 4162 - 4175. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, M. M.W. Chong, R. Darwiche, H. E. Thomas, and T. W.H. Kay Severe Pancreatitis with Exocrine Destruction and Increased Islet Neogenesis in Mice with Suppressor of Cytokine Signaling-1 Deficiency Am. J. Pathol., September 1, 2004; 165(3): 913 - 921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Ronn, J. A. Hansen, K. Lindberg, A. E. Karlsen, and N. Billestrup The Effect of Suppressor of Cytokine Signaling 3 on GH Signaling in {beta}-Cells Mol. Endocrinol., September 1, 2002; 16(9): 2124 - 2134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |